BIO-UV GROUP SAS (ALTUV.PA) Fundamental Analysis & Valuation

EPA:ALTUV • FR0013345493

Current stock price

1.345 EUR
+0.04 (+3.46%)
Last:

This ALTUV.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. ALTUV.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALTUV was profitable.
  • In the past year ALTUV had a positive cash flow from operations.
  • ALTUV had positive earnings in each of the past 5 years.
  • ALTUV had a positive operating cash flow in 4 of the past 5 years.
ALTUV.PA Yearly Net Income VS EBIT VS OCF VS FCFALTUV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M

1.2 Ratios

  • ALTUV has a Return On Assets of 1.36%. This is in the lower half of the industry: ALTUV underperforms 60.38% of its industry peers.
  • ALTUV has a Return On Equity of 2.41%. This is in the lower half of the industry: ALTUV underperforms 66.98% of its industry peers.
  • ALTUV has a Return On Invested Capital of 2.84%. This is in the lower half of the industry: ALTUV underperforms 70.75% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ALTUV is below the industry average of 8.58%.
Industry RankSector Rank
ROA 1.36%
ROE 2.41%
ROIC 2.84%
ROA(3y)1.16%
ROA(5y)1.09%
ROE(3y)2.65%
ROE(5y)2.43%
ROIC(3y)3.91%
ROIC(5y)3.06%
ALTUV.PA Yearly ROA, ROE, ROICALTUV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

  • With a Profit Margin value of 2.64%, ALTUV perfoms like the industry average, outperforming 47.17% of the companies in the same industry.
  • ALTUV's Profit Margin has declined in the last couple of years.
  • ALTUV has a Operating Margin (5.93%) which is in line with its industry peers.
  • In the last couple of years the Operating Margin of ALTUV has grown nicely.
  • ALTUV has a Gross Margin of 38.14%. This is comparable to the rest of the industry: ALTUV outperforms 47.17% of its industry peers.
  • ALTUV's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.93%
PM (TTM) 2.64%
GM 38.14%
OM growth 3Y21.79%
OM growth 5YN/A
PM growth 3Y-66.23%
PM growth 5YN/A
GM growth 3Y1.74%
GM growth 5Y3.01%
ALTUV.PA Yearly Profit, Operating, Gross MarginsALTUV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ALTUV.PA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALTUV is destroying value.
  • Compared to 1 year ago, ALTUV has less shares outstanding
  • Compared to 5 years ago, ALTUV has more shares outstanding
  • The debt/assets ratio for ALTUV has been reduced compared to a year ago.
ALTUV.PA Yearly Shares OutstandingALTUV.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ALTUV.PA Yearly Total Debt VS Total AssetsALTUV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • ALTUV has an Altman-Z score of 1.37. This is a bad value and indicates that ALTUV is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.37, ALTUV is doing worse than 68.87% of the companies in the same industry.
  • The Debt to FCF ratio of ALTUV is 7.69, which is on the high side as it means it would take ALTUV, 7.69 years of fcf income to pay off all of its debts.
  • ALTUV's Debt to FCF ratio of 7.69 is in line compared to the rest of the industry. ALTUV outperforms 46.23% of its industry peers.
  • ALTUV has a Debt/Equity ratio of 0.39. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of ALTUV (0.39) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 7.69
Altman-Z 1.37
ROIC/WACC0.41
WACC6.85%
ALTUV.PA Yearly LT Debt VS Equity VS FCFALTUV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

  • A Current Ratio of 2.05 indicates that ALTUV has no problem at all paying its short term obligations.
  • ALTUV's Current ratio of 2.05 is fine compared to the rest of the industry. ALTUV outperforms 79.25% of its industry peers.
  • A Quick Ratio of 1.31 indicates that ALTUV should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.31, ALTUV is in the better half of the industry, outperforming 73.58% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.05
Quick Ratio 1.31
ALTUV.PA Yearly Current Assets VS Current LiabilitesALTUV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ALTUV.PA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 190.18% over the past year.
  • The earnings per share for ALTUV have been decreasing by -64.42% on average. This is quite bad
  • ALTUV shows a decrease in Revenue. In the last year, the revenue decreased by -7.99%.
  • The Revenue has been growing by 14.65% on average over the past years. This is quite good.
EPS 1Y (TTM)190.18%
EPS 3Y-64.42%
EPS 5YN/A
EPS Q2Q%167.3%
Revenue 1Y (TTM)-7.99%
Revenue growth 3Y5.76%
Revenue growth 5Y14.65%
Sales Q2Q%-7.98%

3.2 Future

  • The Earnings Per Share is expected to grow by 11.91% on average over the next years. This is quite good.
  • Based on estimates for the next years, ALTUV will show a small growth in Revenue. The Revenue will grow by 1.00% on average per year.
EPS Next Y-29.92%
EPS Next 2Y-16.29%
EPS Next 3Y11.91%
EPS Next 5YN/A
Revenue Next Year0%
Revenue Next 2Y-1.4%
Revenue Next 3Y1%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALTUV.PA Yearly Revenue VS EstimatesALTUV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M 50M
ALTUV.PA Yearly EPS VS EstimatesALTUV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3 0.4

More info and screens

Find the best growth stocksShow best growing peers

4

4. ALTUV.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 19.21, the valuation of ALTUV can be described as rather expensive.
  • Based on the Price/Earnings ratio, ALTUV is valued a bit cheaper than the industry average as 62.26% of the companies are valued more expensively.
  • ALTUV is valuated rather cheaply when we compare the Price/Earnings ratio to 26.91, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 18.65, ALTUV is valued on the expensive side.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ALTUV is on the same level as its industry peers.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.69, ALTUV is valued a bit cheaper.
Industry RankSector Rank
PE 19.21
Fwd PE 18.65
ALTUV.PA Price Earnings VS Forward Price EarningsALTUV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ALTUV is valued a bit cheaper than the industry average as 60.38% of the companies are valued more expensively.
  • ALTUV's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ALTUV is cheaper than 83.96% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.93
EV/EBITDA 8.25
ALTUV.PA Per share dataALTUV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-16.29%
EPS Next 3Y11.91%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. ALTUV.PA Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.50%, ALTUV has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 1.64, ALTUV pays a bit more dividend than its industry peers.
  • ALTUV's Dividend Yield is a higher than the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 2.5%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ALTUV.PA Yearly Dividends per shareALTUV.PA Yearly Dividends per shareYearly Dividends per share 2023 0 0 0 0 0

5.3 Sustainability

DP0%
EPS Next 2Y-16.29%
EPS Next 3Y11.91%
ALTUV.PA Yearly Income VS Free CF VS DividendALTUV.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M

More info and screens

Find the best dividend stocksShow peers with best dividend

ALTUV.PA Fundamentals: All Metrics, Ratios and Statistics

BIO-UV GROUP SAS

EPA:ALTUV (4/8/2026, 7:00:00 PM)

1.345

+0.04 (+3.46%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)N/A
Earnings (Next)04-08
Inst Owners5.54%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap19.03M
Revenue(TTM)37.81M
Net Income(TTM)996.80K
Analysts86.67
Price Target2.55 (89.59%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.5%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-16.67%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 19.21
Fwd PE 18.65
P/S 0.5
P/FCF 6.93
P/OCF 3.99
P/B 0.46
P/tB 3.71
EV/EBITDA 8.25
EPS(TTM)0.07
EY5.2%
EPS(NY)0.07
Fwd EY5.36%
FCF(TTM)0.19
FCFY14.43%
OCF(TTM)0.34
OCFY25.05%
SpS2.67
BVpS2.93
TBVpS0.36
PEG (NY)N/A
PEG (5Y)N/A
Graham Number2.15
Profitability
Industry RankSector Rank
ROA 1.36%
ROE 2.41%
ROCE 3.87%
ROIC 2.84%
ROICexc 2.84%
ROICexgc 7.55%
OM 5.93%
PM (TTM) 2.64%
GM 38.14%
FCFM 7.26%
ROA(3y)1.16%
ROA(5y)1.09%
ROE(3y)2.65%
ROE(5y)2.43%
ROIC(3y)3.91%
ROIC(5y)3.06%
ROICexc(3y)4.12%
ROICexc(5y)3.44%
ROICexgc(3y)16.95%
ROICexgc(5y)12.95%
ROCE(3y)5.34%
ROCE(5y)4.18%
ROICexgc growth 3Y38.43%
ROICexgc growth 5YN/A
ROICexc growth 3Y32.09%
ROICexc growth 5YN/A
OM growth 3Y21.79%
OM growth 5YN/A
PM growth 3Y-66.23%
PM growth 5YN/A
GM growth 3Y1.74%
GM growth 5Y3.01%
F-Score7
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 7.69
Debt/EBITDA 3.38
Cap/Depr 79.6%
Cap/Sales 5.35%
Interest Coverage 250
Cash Conversion 99.7%
Profit Quality 275.52%
Current Ratio 2.05
Quick Ratio 1.31
Altman-Z 1.37
F-Score7
WACC6.85%
ROIC/WACC0.41
Cap/Depr(3y)64.42%
Cap/Depr(5y)89.94%
Cap/Sales(3y)4.59%
Cap/Sales(5y)6.26%
Profit Quality(3y)6416.11%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)190.18%
EPS 3Y-64.42%
EPS 5YN/A
EPS Q2Q%167.3%
EPS Next Y-29.92%
EPS Next 2Y-16.29%
EPS Next 3Y11.91%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.99%
Revenue growth 3Y5.76%
Revenue growth 5Y14.65%
Sales Q2Q%-7.98%
Revenue Next Year0%
Revenue Next 2Y-1.4%
Revenue Next 3Y1%
Revenue Next 5YN/A
EBIT growth 1Y9.21%
EBIT growth 3Y28.8%
EBIT growth 5YN/A
EBIT Next Year128.57%
EBIT Next 3Y40.3%
EBIT Next 5YN/A
FCF growth 1Y112.9%
FCF growth 3Y105.52%
FCF growth 5YN/A
OCF growth 1Y18.9%
OCF growth 3Y27.9%
OCF growth 5YN/A

BIO-UV GROUP SAS / ALTUV.PA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for BIO-UV GROUP SAS?

ChartMill assigns a fundamental rating of 4 / 10 to ALTUV.PA.


What is the valuation status of BIO-UV GROUP SAS (ALTUV.PA) stock?

ChartMill assigns a valuation rating of 4 / 10 to BIO-UV GROUP SAS (ALTUV.PA). This can be considered as Fairly Valued.


What is the profitability of ALTUV stock?

BIO-UV GROUP SAS (ALTUV.PA) has a profitability rating of 4 / 10.


Can you provide the expected EPS growth for ALTUV stock?

The Earnings per Share (EPS) of BIO-UV GROUP SAS (ALTUV.PA) is expected to decline by -29.92% in the next year.


How sustainable is the dividend of BIO-UV GROUP SAS (ALTUV.PA) stock?

The dividend rating of BIO-UV GROUP SAS (ALTUV.PA) is 3 / 10 and the dividend payout ratio is 0%.